SHP Wealth Management’s Mersana Therapeutics MRSN Stock Holding History

SHP Wealth Management’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25	Closed	-$723	–	1883
2025 Q4	$723	Buy	+25	New	+$475	﹤0.01%	1307

Other funds holding MRSN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SHP Wealth Management's MRSN Position: Q1 2026 in Review

SHP Wealth Management sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 25 shares — an estimated $723 sold.

SHP Wealth Management first reported a position in MRSN in Q4 2025 and held it in 1 quarter. The position peaked at $723 in Q4 2025. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.

SHP Wealth Management reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
SHP Wealth Management sold 25 Mersana Therapeutics shares in Q1 2026, an estimated $723.
SHP Wealth Management first reported a position in Mersana Therapeutics in Q4 2025 and held it in 1 quarter.
SHP Wealth Management's Mersana Therapeutics position peaked at $723 in Q4 2025.
1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.